H6phospa-trastuzumab: bifunctional methylenephosphonate-based chelator with 89Zr, 111In and 177Lu.
about
Evaluation of macrocyclic hydroxyisophthalamide ligands as chelators for zirconium-89Rational design, synthesis, and evaluation of tetrahydroxamic acid chelators for stable complexation of zirconium(IV)Tripodal tris(hydroxypyridinone) ligands for immunoconjugate PET imaging with (89)Zr(4+): comparison with desferrioxamine-B.p-SCN-Bn-HOPO: A Superior Bifunctional Chelator for (89)Zr ImmunoPET[(64) Cu]-labelled trastuzumab: optimisation of labelling by DOTA and NODAGA conjugation and initial evaluation in mice.Comparison of the octadentate bifunctional chelator DFO*-pPhe-NCS and the clinically used hexadentate bifunctional chelator DFO-pPhe-NCS for 89Zr-immuno-PETZirconium tetraazamacrocycle complexes display extraordinary stability and provide a new strategy for zirconium-89-based radiopharmaceutical development.Matching chelators to radiometals for radiopharmaceuticals.Radiometals: towards a new success story in nuclear imaging?In vivo imaging with antibodies and engineered fragments.Current advances in ligand design for inorganic positron emission tomography tracers (68)Ga, (64)Cu, (89)Zr and (44)Sc.Investigation of the complexation of natZr(iv) and 89Zr(iv) by hydroxypyridinones for the development of chelators for PET imaging applications.Modular syntheses of H₄octapa and H₂dedpa, and yttrium coordination chemistry relevant to ⁸⁶Y/⁹⁰Y radiopharmaceuticals.89Zr-Immuno-Positron Emission Tomography in Oncology: State-of-the-Art 89Zr Radiochemistry.What a difference a carbon makes: H₄octapa vs H₄C3octapa, ligands for In-111 and Lu-177 radiochemistry.H4octapa: synthesis, solution equilibria and complexes with useful radiopharmaceutical metal ions.A new tetrapodal 3-hydroxy-4-pyridinone ligand for complexation of 89zirconium for positron emission tomography (PET) imaging.A desferrioxamine B squaramide ester for the incorporation of zirconium-89 into antibodies.
P2860
Q33757834-B0BD12FC-410E-4B4C-BE0F-9BC549E1F25BQ34009558-541AACE0-0D14-43A7-8A35-23AAD36BAFF7Q35170338-FE6463FF-E89A-4CB6-8C65-703A098CE4B6Q37129847-F154232D-FE85-4AAF-AF2A-1409636E7C54Q37268891-EAD9FDD0-CDC1-411F-BCE4-491DAEA4C7D9Q37560052-AA5715E1-6C60-420D-AB61-CA15000A7AA8Q37718007-EB8D5411-B9B3-4D0C-AA9F-B26A6E13F2C0Q38156660-2CD8484F-2C74-4880-B34D-C0AB7C71CCBCQ38273277-A55D0011-398E-4158-8064-4A49FB388750Q38454458-0F09C425-6E35-4346-A6BE-507B404013BAQ38729041-2ACEA73A-BC8C-4693-99EC-AEA33A85D90FQ38880203-E53C511A-2A49-49D3-8205-BB7F9B705F70Q39221164-C5C52E31-8A58-4897-9D5D-E19A3CD9760BQ41690954-78D1F609-45DB-4215-BFAA-A037D813FEB8Q41845074-26EBE057-C9D4-4F57-8F9D-5F8B647E31BAQ46314544-E83AA752-7763-40C0-85C9-CE9293175BFDQ48118923-3B5AC1E0-60CB-452E-A436-91E5A6A4BB7CQ52845355-075F4AF1-5FE5-49F6-892E-7F74F681956B
P2860
H6phospa-trastuzumab: bifunctional methylenephosphonate-based chelator with 89Zr, 111In and 177Lu.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
H6phospa-trastuzumab: bifuncti ...... or with 89Zr, 111In and 177Lu.
@en
H6phospa-trastuzumab: bifuncti ...... or with 89Zr, 111In and 177Lu.
@nl
type
label
H6phospa-trastuzumab: bifuncti ...... or with 89Zr, 111In and 177Lu.
@en
H6phospa-trastuzumab: bifuncti ...... or with 89Zr, 111In and 177Lu.
@nl
prefLabel
H6phospa-trastuzumab: bifuncti ...... or with 89Zr, 111In and 177Lu.
@en
H6phospa-trastuzumab: bifuncti ...... or with 89Zr, 111In and 177Lu.
@nl
P2093
P2860
P356
P1433
P1476
H6phospa-trastuzumab: bifuncti ...... tor with 89Zr, 111In and 177Lu
@en
P2093
Brian M Zeglis
Chris Orvig
Eric W Price
Michael J Adam
P2860
P304
P356
10.1039/C3DT51940F
P407
P577
2014-01-01T00:00:00Z